|
|
|
|
LEADER |
05446nma a2201777 u 4500 |
001 |
EB002048452 |
003 |
EBX01000000000000001192118 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
220822 ||| eng |
020 |
|
|
|a 9783036516431
|
020 |
|
|
|a 9783036516448
|
020 |
|
|
|a books978-3-0365-1643-1
|
100 |
1 |
|
|a Marino, Angela
|
245 |
0 |
0 |
|a Cellular Oxidative Stress
|h Elektronische Ressource
|
260 |
|
|
|a Basel, Switzerland
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2021
|
300 |
|
|
|a 1 electronic resource (529 p.)
|
653 |
|
|
|a antioxidant
|
653 |
|
|
|a cardiovascular diseases
|
653 |
|
|
|a aging
|
653 |
|
|
|a 3-glutathionyl-4-hydroxynonanal
|
653 |
|
|
|a luteolin
|
653 |
|
|
|a diet
|
653 |
|
|
|a immunosenescence
|
653 |
|
|
|a A2E
|
653 |
|
|
|a programmed cell death
|
653 |
|
|
|a tert-Bytyl hydroperoxide t-BOOH
|
653 |
|
|
|a Retinitis pigmentosa
|
653 |
|
|
|a antioxidants
|
653 |
|
|
|a simvastatin
|
653 |
|
|
|a artemisinin derivatives
|
653 |
|
|
|a syk kinase inhibitors
|
653 |
|
|
|a RNA-Seq
|
653 |
|
|
|a epilepsy
|
653 |
|
|
|a paracrine factors
|
653 |
|
|
|a tRNA fragments
|
653 |
|
|
|a ferroptosis
|
653 |
|
|
|a soy foods
|
653 |
|
|
|a adaptive immune response
|
653 |
|
|
|a platelets
|
653 |
|
|
|a neurodegeneration
|
653 |
|
|
|a soy
|
653 |
|
|
|a Plasmodium falciparum
|
653 |
|
|
|a neuroinflammation
|
653 |
|
|
|a Band 3 protein
|
653 |
|
|
|a anion exchange
|
653 |
|
|
|a reactive oxygen species
|
653 |
|
|
|a clinical
|
653 |
|
|
|a Trolox
|
653 |
|
|
|a adipose-derived stem cells
|
653 |
|
|
|a NF-κB
|
653 |
|
|
|a nasal immunity
|
653 |
|
|
|a SO42−
|
653 |
|
|
|a astrocytoma cells
|
653 |
|
|
|a cancer
|
653 |
|
|
|a lncRNA
|
653 |
|
|
|a diabetes
|
653 |
|
|
|a soybeans
|
653 |
|
|
|a ncRNA
|
653 |
|
|
|a vitamin C
|
653 |
|
|
|a paw edema
|
653 |
|
|
|a bradykinin
|
653 |
|
|
|a autophagy
|
653 |
|
|
|a mitochondrial function
|
653 |
|
|
|a coagulation
|
653 |
|
|
|a calcium ionophore A23187
|
653 |
|
|
|a glycation
|
653 |
|
|
|a matrix metalloproteinases
|
653 |
|
|
|a status epilepticus
|
653 |
|
|
|a reactive oxygen species (ROS)
|
653 |
|
|
|a acute pancreatitis
|
653 |
|
|
|a age-related macular degeneration (AMD)
|
653 |
|
|
|a immune system
|
653 |
|
|
|a Medicine and Nursing / bicssc
|
653 |
|
|
|a band 3
|
653 |
|
|
|a cell homeostasis
|
653 |
|
|
|a vaccination
|
653 |
|
|
|a preeclampsia
|
653 |
|
|
|a polyphenols
|
653 |
|
|
|a liver
|
653 |
|
|
|a glucose exposure
|
653 |
|
|
|a phytochemicals
|
653 |
|
|
|a nitrosative stress
|
653 |
|
|
|a NAC
|
653 |
|
|
|a palmitoylethanolamide (PEA)
|
653 |
|
|
|a matrix metalloproteinase
|
653 |
|
|
|a vesiculation
|
653 |
|
|
|a d-Galactose
|
653 |
|
|
|a natural compounds
|
653 |
|
|
|a prooxidant
|
653 |
|
|
|a pyroptosis
|
653 |
|
|
|a inflammation
|
653 |
|
|
|a analgesic
|
653 |
|
|
|a fish
|
653 |
|
|
|a mucosal immunity
|
653 |
|
|
|a n/a
|
653 |
|
|
|a AVD
|
653 |
|
|
|a therapeutic strategies
|
653 |
|
|
|a nasal fibroblasts
|
653 |
|
|
|a microvascular permeability
|
653 |
|
|
|a diseases
|
653 |
|
|
|a NADPH oxidase
|
653 |
|
|
|a cellular redox state
|
653 |
|
|
|a circRNA
|
653 |
|
|
|a palmitoylethanolamide
|
653 |
|
|
|a traumatic brain injury
|
653 |
|
|
|a ROS
|
653 |
|
|
|a hemichromes
|
653 |
|
|
|a HeLa
|
653 |
|
|
|a steroids
|
653 |
|
|
|a RPE
|
653 |
|
|
|a molecular hydrogen
|
653 |
|
|
|a apoptosis
|
653 |
|
|
|a legumes
|
653 |
|
|
|a peroxide
|
653 |
|
|
|a interleukin 1β
|
653 |
|
|
|a cisplatin nephrotoxicity
|
653 |
|
|
|a cashew nuts
|
653 |
|
|
|a SO42− uptake
|
653 |
|
|
|a Substance-P
|
653 |
|
|
|a obesity
|
653 |
|
|
|a hemostasis
|
653 |
|
|
|a oxidative stress.
|
653 |
|
|
|a co-ultramicronization
|
653 |
|
|
|a 4-hydroxy-2-nonenal
|
653 |
|
|
|a cigarette smoke extract
|
653 |
|
|
|a microparticles
|
653 |
|
|
|a PGC-1α
|
653 |
|
|
|a oxidative stress
|
653 |
|
|
|a dietary chemicals
|
653 |
|
|
|a lipid dyshomeostasis
|
653 |
|
|
|a T cells
|
653 |
|
|
|a nitric oxide donor
|
653 |
|
|
|a miRNA
|
653 |
|
|
|a erythrocytes
|
653 |
|
|
|a hepatic steatosis
|
653 |
|
|
|a CNS pathology
|
653 |
|
|
|a anoikis
|
653 |
|
|
|a tissue inhibitor of metalloproteinases
|
700 |
1 |
|
|a Dossena, Silvia
|
700 |
1 |
|
|a Marino, Angela
|
700 |
1 |
|
|a Dossena, Silvia
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
024 |
8 |
|
|a 10.3390/books978-3-0365-1643-1
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/4048
|7 0
|x Verlag
|3 Volltext
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/76603
|z DOAB: description of the publication
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 700
|
520 |
|
|
|a This book collects 17 original research papers and 9 reviews that are part of the Special Issue "Cellular Oxidative Stress", published in the journal Antioxidants. Oxidative stress on a cellular level affects the function of tissues and organs and may eventually lead to disease. Therefore, a precise understanding of how oxidative stress develops and can be counteracted is of utmost importance. The scope of the book is to emphasize the latest findings on the cellular targets of oxidative stress and the potential beneficial effect of antioxidants on human health.
|